FDG-PET in radiotherapy treatment planning: Pandora's box?

被引：128
作者：
Paulino, AC
Johnstone, PAS
机构：
[1] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2004年 / 59卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2003.10.045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
No abstract available
引用
收藏
页码：4 / 5
页数：2
相关论文
共 12 条
  • [1] Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer
    Bradley, J
    Thorstad, WL
    Mutic, S
    Miller, TR
    Dehdashti, F
    Siegel, BA
    Bosch, W
    Bertrand, RJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01): : 78 - 86
  • [2] Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
  • [3] Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET)
    Erdi, YE
    Rosenzweig, K
    Erdi, AK
    Macapinlac, HA
    Hu, YC
    Braban, LE
    Humm, JL
    Squire, OD
    Chui, CS
    Larson, SM
    Yorke, ED
    [J]. RADIOTHERAPY AND ONCOLOGY, 2002, 62 (01) : 51 - 60
  • [4] THE ROGERS,WILL PHENOMENON - STAGE MIGRATION AND NEW DIAGNOSTIC-TECHNIQUES AS A SOURCE OF MISLEADING STATISTICS FOR SURVIVAL IN CANCER
    FEINSTEIN, AR
    SOSIN, DM
    WELLS, CK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (25) : 1604 - 1608
  • [5] Clinical impact of 18F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer:: A prospective study
    Kalff, V
    Hicks, RJ
    MacManus, MP
    Binns, DS
    McKenzie, AF
    Ware, RE
    Hogg, A
    Ball, DL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) : 111 - 118
  • [6] The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer
    Kiffer, JD
    Berlangieri, SU
    Scott, AM
    Quong, G
    Feigen, M
    Schumer, W
    Clarke, CP
    Knight, SR
    Daniel, FJ
    [J]. LUNG CANCER, 1998, 19 (03) : 167 - 177
  • [7] Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography
    Lardinois, D
    Weder, W
    Hany, TF
    Kamel, EM
    Korom, S
    Seifert, B
    von Schulthess, GK
    Steinert, HC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25) : 2500 - 2507
  • [8] Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer
    Mac Manus, MP
    Hicks, RJ
    Matthews, JP
    McKenzie, A
    Rischin, D
    Salminen, EK
    Ball, DL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) : 1285 - 1292
  • [9] The impact of 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma:: A prospective study
    Mah, K
    Caldwell, CB
    Ung, YC
    Danjoux, CE
    Balogh, JM
    Ganguli, SN
    Ehrlich, LE
    Tirona, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (02): : 339 - 350
  • [10] 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer:: High impact in patients with atelectasis
    Nestle, U
    Walter, K
    Schmidt, S
    Licht, N
    Nieder, C
    Motaref, B
    Hellwig, D
    Niewald, M
    Ukena, D
    Kirsch, CM
    Sybrecht, GW
    Schnabel, K
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (03): : 593 - 597
12